iBio, Inc. (IBIO): Total Liabilities
$13.40M
As of 2026-06-30
-19.7%
3-year compound annual growth
-19.0%
5-year compound annual growth
-7.0%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $13.40M | +61.3% | 2026-08-28, Balance as of period end |
| 2025-06-30 | $8.30M | +12.1% | 2026-08-28, Balance as of period end |
| 2024-06-30 | $7.41M | -71.3% | 2025-09-05, Balance as of period end |
| 2023-06-30 | $25.83M | -28.1% | 2024-09-24, Balance as of period end |
| 2022-06-30 | $35.92M | -6.5% | 2023-09-27, Balance as of period end |
| 2021-06-30 | $38.40M | +2.2% | 2022-10-11, Balance as of period end |
| 2020-06-30 | $37.58M | +33.6% | 2021-09-28, Balance as of period end |
| 2019-06-30 | $28.13M | +4.5% | 2020-10-13, Balance as of period end |
| 2018-06-30 | $26.92M | -0.6% | 2019-08-26, Balance as of period end |
| 2017-06-30 | $27.09M | -1.7% | 2018-09-18, Balance as of period end |
| 2016-06-30 | $27.56M | n/m | 2017-09-15, Balance as of period end |
| 2015-06-30 | $1.26M | +219.7% | 2016-10-13, Balance as of period end |
| 2014-06-30 | $395.0K | n/a | 2015-10-13, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| iBio, Inc. (IBIO) | 2026-06-30 | $13.40M | +61.3% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $43.94M | -0.5% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $672.0K | +14.3% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $1.30M | -45.3% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $14.10M | +54.6% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $3.14M | -44.7% |
Compare IBIO, ATNM, BFRG, SER side by side · Screen every company in Pharmaceutical Preparations ↗